N-glycosylation modification of plant-derived virus-like particles: An application in vaccines

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kim, Hyun Soon ^a   Jeon, Jae Heung ^a   Lee, Kyung Jin ^b   Ko, Kisung ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOSYLTRANSFERASE; RECOMBINANT PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VACCINE; GLYCOPROTEIN; VIRUS LIKE PARTICLE VACCINE;

ARTICLE; ENDOPLASMIC RETICULUM; GENE EXPRESSION SYSTEM; GENE INACTIVATION; GLYCOSYLATION; NONHUMAN; PLANT VIRUS; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; VIRUS LIKE AGENT; ANIMAL; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHARMACEUTICS; PLANT; PROCEDURES; TRANSGENIC PLANT;

ANIMALS; GENE EXPRESSION; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; PLANTS; PLANTS, GENETICALLY MODIFIED; PROTEIN PROCESSING, POST-TRANSLATIONAL; TECHNOLOGY, PHARMACEUTICAL; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84902154526     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/249519     Document Type: Article

References (78)

1. Lico C., Schoubben A., Baschieri S., Blasi P., Santi L., Nanoparticles in biomedicine: new insights from plant viruses. Current Medicinal Chemistry 2013 20 28 3471 3487 10.2174/09298673113209990035
2. Grasso S., Santi L., Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches. International Journal of Physiology, Pathophysiology and Pharmacology 2010 2 2 161 178 2-s2.0-77954713640
3. Pokorski J. K., Steinmetz N. F., The art of engineering viral nanoparticles. Molecular Pharmaceutics 2011 8 1 29 43 2-s2.0-79952975902 10.1021/mp100225y
4. Bachmann A. S., Corpuz G., Hareld W. P., Wang G., Coller B. A., A simple method for the rapid purification of copia virus-like particles from Drosophila Schneider 2 cells. Journal of Virological Methods 2004 115 2 159 165 2-s2.0-0345167812 10.1016/j.jviromet.2003.09.025 (Pubitemid 37506030)
5. Chen Q., Lai H., Plant-derived virus-like particles as vaccines. Human Vaccines and Immunotherapeutics 2013 9 1 26 49 2-s2.0-84874755493 10.4161/hv.22218
6. Kushnir N., Streatfield S. J., Yusibov V., Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 2012 31 1 58 83 2-s2.0-84870540478 10.1016/j.vaccine.2012.10.083
7. Herscovics A., Orlean P., Glycoprotein biosynthesis in yeast. The FASEB Journal 1993 7 6 540 550 2-s2.0-0027402074 (Pubitemid 23120901)
8. Wildt S., Gerngross T. U., The humanization of N -glycosylation pathways in yeast. Nature Reviews Microbiology 2005 3 2 119 128 2-s2.0-13444262282 10.1038/nrmicro1087 (Pubitemid 40207593)
9. Harrison R. L., Jarvis D. L., Protein N -glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce "mammalianized" recombinant glycoproteins. Advances in Virus Research 2006 68 159 191 2-s2.0-33748742271 10.1016/S0065-3527(06)68005-6 (Pubitemid 44402211)
10. Schwarzer J., Rapp E., Reichl U., N -glycan analysis by CGE-LIF: profiling influenza A virus hemagglutinin N -glycosylation during vaccine production. Electrophoresis 2008 29 20 4203 4214 2-s2.0-56849090276 10.1002/elps.200800042
11. Hamby S. E., Hirst J. D., Prediction of glycosylation sites using random forests. BMC Bioinformatics 2008 9, article 500 2-s2.0-62149135362 10.1186/1471-2105-9-500
12. Faye L., Gomord V., Success stories in molecular farming-a brief overview. Plant Biotechnology Journal 2010 8 5 525 528 2-s2.0-77954018329 10.1111/j.1467-7652.2010.00521.x
13. Giddings G., Allison G., Brooks D., Carter A., Transgenic plants as factories for biopharmaceuticals. Nature Biotechnology 2000 18 11 1151 1155 2-s2.0-0033758021 10.1038/81132
14. Roldao A., Mellado M. C., Castilho L. R., Carrondo M. J., Alves P. M., Virus-like particles in vaccine development. Expert Review of Vaccines 2010 9 10 1149 1176 2-s2.0-77957936654 10.1586/erv.10.115
15. Lai H., Chen Q., Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. Plant Cell Reports 2012 31 3 573 584 2-s2.0-84856962688 10.1007/s00299-011-1196-6
16. Gleba Y., Klimyuk V., Marillonnet S., Viral vectors for the expression of proteins in plants. Current Opinion in Biotechnology 2007 18 2 134 141 2-s2.0-34147095513 10.1016/j.copbio.2007.03.002 (Pubitemid 46575232)
17. Santi L., Batchelor L., Huang Z., An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008 26 15 1846 1854 2-s2.0-40849140609 10.1016/j.vaccine.2008.01.053
18. Chapman S., Kavanagh T., Baulcombe D., Potato virus X as a vector for gene expression in plants. The Plant Journal 1992 2 4 549 557 2-s2.0-0026892978
19. Cerovska N., Hoffmeisterova H., Moravec T., Transient expression of Human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of Potato virus X in plants. Journal of Biosciences 2012 37 1 125 133 2-s2.0-84859744586 10.1007/s12038-011-9177-z
20. Chatterji A., Ochoa W. F., Paine M., Ratna B. R., Johnson J. E., Lin T., New addresses on an addressable virus nanoblock: uniquely reactive Lys residues on cowpea mosaic virus. Chemistry and Biology 2004 11 6 855 863 2-s2.0-3042688833 10.1016/j.chembiol.2004.04.011 (Pubitemid 38836901)
21. Zhang X., Mason H., Bean Yellow Dwarf Virus replicons for high-level transgene expression in transgenic plants and cell cultures. Biotechnology and Bioengineering 2006 93 2 271 279 2-s2.0-33645568800 10.1002/bit.20695
22. Liu L., Davies J. W., Stanley J., Mutational analysis of bean yellow dwarf virus, a geminivirus of the genus Mastrevirus that is adapted to dicotyledonous plants. Journal of General Virology 1998 79 2265 2274 2-s2.0-0031669168 (Pubitemid 28423423)
23. Smith M. L., Lindbo J. A., Dillard-Telm S., Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Virology 2006 348 2 475 488 2-s2.0-33646256795 10.1016/j.virol.2005.12.039
24. Conti G., Rodriguez M. C., Manacorda C. A., Asurmendi S., Transgenic expression of Tobacco mosaic virus capsid and movement proteins modulate plant basal defense and biotic stress responses in Nicotiana tabacum. Molecular Plant-Microbe Interactions 2012 25 10 1370 1384 2-s2.0-84865766853 10.1094/MPMI-03-12-0075-R
25. Tsuda S., Yoshioka K., Tanaka T., Application of the human hepatitis B virus core antigen from transgenic tobacco plants for serological diagnosis. Vox Sanguinis 1998 74 3 148 155 2-s2.0-0031980924 10.1159/000030923 (Pubitemid 28167612)
26. Sojikul P., Buehner N., Mason H. S., A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 5 2209 2214 2-s2.0-0037418173 10.1073/pnas.0438037100 (Pubitemid 36297478)
27. Mechtcheriakova I. A., Eldarov M. A., Nicholson L., Shanks M., Skryabin K. G., Lomonossoff G. P., The use of viral vectors to produce hepatitis B virus core particles in plants. Journal of Virological Methods 2006 131 1 10 15 2-s2.0-28844438905 10.1016/j.jviromet.2005.06.020 (Pubitemid 41772554)
28. Huang Z., Mason H. S., Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium -mediated transient expression system. Plant Biotechnology Journal 2004 2 3 241 249 2-s2.0-13244262550 10.1111/j.1467-7652. 2004.00068.x (Pubitemid 40199456)
29. Warzecha H., Mason H. S., Lane C., Oral immunogenicity of human papillomavirus-like particles expressed in potato. Journal of Virology 2003 77 16 8702 8711 2-s2.0-0042709462 10.1128/JVI.77.16.8702-8711.2003 (Pubitemid 36936081)
30. Varsani A., Williamson A. L., Stewart D., Rybicki E. P., Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. Virus Research 2006 120 1-2 91 96 2-s2.0-33745341751 10.1016/j.virusres.2006.01.022 (Pubitemid 43947302)
31. Varsani A., Williamson A.-L., Rose R. C., Jaffer M., Rybicki E. P., Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Archives of Virology 2003 148 9 1771 1786 2-s2.0-0141674634 10.1007/s00705-003-0119-4 (Pubitemid 37144180)
32. Huang Z., Chen Q., Hjelm B., Arntzen C., Mason H., A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnology and Bioengineering 2009 103 4 706 714 2-s2.0-67650156117 10.1002/bit.22299
33. He J., Lai H., Brock C., Chen Q., A novel system for rapid and cost-effective production of detection and diagnostic reagents of West Nile virus in plants. Journal of Biomedicine and Biotechnology 2012 2012 10 2-s2.0-84855543357 10.1155/2012/106783 106783
34. Hefferon K. L., Broadly neutralizing antibodies and the promise of universal vaccines: where are we now? Immunotherapy 2014 6 1 51 57 10.2217/imt.13.150
35. Huang Z., Santi L., LePore K., Kilbourne J., Arntzen C. J., Mason H. S., Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 2006 24 14 2506 2513 2-s2.0-33344479476 10.1016/j.vaccine.2005.12.024 (Pubitemid 43290380)
36. Lambert C., Thome N., Kluck C. J., Prange R., Functional incorporation of green fluorescent protein into hepatitis B virus envelope particles. Virology 2004 330 1 158 167 2-s2.0-7444256599 10.1016/j.virol.2004.09.031 (Pubitemid 39446575)
37. Chen Q., He J., Phoolcharoen W., Mason H. S., Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Human Vaccines 2011 7 3 331 338 2-s2.0-79953675401 10.4161/hv.7.3.14262
38. Ravin N. V., Kotlyarov R. Y., Mardanova E. S., Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry 2012 77 1 33 40 2-s2.0-84856620470 10.1134/S000629791201004X
39. de la Rosa G. P., Monroy-Garcia A., de Lourdes Mora-García M., An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice. Virology Journal 2009 6, article 2 2-s2.0-60349104850 10.1186/1743-422X-6-2
40. Santi L., Huang Z., Mason H., Virus-like particles production in green plants. Methods 2006 40 1 66 76 2-s2.0-33748780696 10.1016/j.ymeth.2006.05.020 (Pubitemid 44415500)
41. Huang Z., Elkin G., Maloney B. J., Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 2005 23 15 1851 1858 2-s2.0-14744283794 10.1016/j.vaccine.2004.11.017 (Pubitemid 40331858)
42. Shchelkunov S. N., Salyaev R. K., Pozdnyakov S. G., Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnology Letters 2006 28 13 959 967 2-s2.0-33745683684 10.1007/s10529-006-9028-4 (Pubitemid 44000020)
43. Branco L. M., Grove J. N., Geske F. J., Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virology Journal 2010 7, article 279 2-s2.0-77957993361 10.1186/1743-422X-7-279
44. Dietzgen R. G., Francki R. I., Analysis of lettuce necrotic yellows virus structural proteins with monoclonal antibodies and concanavalin A. Virology 1988 166 2 486 494 2-s2.0-0024094448
45. Baratova L. A., Fedorova N. V., Dobrov E. N., N -terminal segment of potato virus X coat protein subunits is glycosylated and mediates formation of a bound water shell on the virion surface. European Journal of Biochemistry 2004 271 15 3136 3145 2-s2.0-3242884954 10.1111/j.1432-1033.2004.04243.x (Pubitemid 38998683)
46. Seddas P., Boissinot S., Glycosylation of beet Western yellows virus proteins is implicated in the aphid transmission of the virus. Archives of Virology 2006 151 5 967 984 2-s2.0-33646012646 10.1007/s00705-005-0669-8
47. Helenius A., Aebi M., Intracellular functions of N -linked glycans. Science 2001 291 5512 2364 2369 2-s2.0-0035937505 10.1126/science.291.5512.2364 (Pubitemid 32231791)
48. Lerouge P., Bardor M., Pagny S., Gomord V., Faye L., N -glycosylation of recombinant pharmaceutical glycoproteins produced in transgenic plants: towards an humanisation of plant N -glycans. Current Pharmaceutical Biotechnology 2000 1 4 347 354 2-s2.0-0034570433
49. Varki A., Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993 3 2 97 130 2-s2.0-0027318961 (Pubitemid 23132602)
50. Gomord V., Fitchette A., Menu-Bouaouiche L., Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnology Journal 2010 8 5 564 587 2-s2.0-77954013882 10.1111/j.1467-7652.2009.00497.x
51. Saint-Jore-Dupas C., Faye L., Gomord V., From planta to pharma with glycosylation in the toolbox. Trends in Biotechnology 2007 25 7 317 323 2-s2.0-34250346068 10.1016/j.tibtech.2007.04.008 (Pubitemid 46908836)
52. Bencurova M., Hemmer W., Focke-Tejkl M., Wilson I. B., Altmann F., Specificity of IgG and IgE antibodies against plant and insect glycoprotein glycans determined with artificial glycoforms of human transferrin. Glycobiology 2004 14 5 457 466 2-s2.0-2942606516 10.1093/glycob/cwh058 (Pubitemid 38744927)
53. Fotisch K., Vieths S., N- and O-linked oligosaccharides of allergenic glycoproteins. Glycoconjugate Journal 2001 18 5 373 390 2-s2.0-0035735890 10.1023/A:1014860030380 (Pubitemid 34461721)
54. van Ree R., Cabanes-Macheteau M., Akkerdaas J., β (1,2)-xylose and α (1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. The Journal of Biological Chemistry 2000 275 15 11451 11458 2-s2.0-0034646714 10.1074/jbc.275.15.11451 (Pubitemid 30212799)
55. Altmann F., The role of protein glycosylation in allergy. International Archives of Allergy and Immunology 2007 142 2 99 115 2-s2.0-33846187538 10.1159/000096114 (Pubitemid 46095922)
56. Bosch D., Castilho A., Loos A., Schots A., Steinkellner H., N -glycosylation of plant-produced recombinant proteins. Current Pharmaceutical Design 2013 19 31 5503 5512 10.2174/1381612811319310006
57. Strasser R., Stadlmann J., Svoboda B., Altmann F., Glossl J., Mach L., Molecular basis of N -acetylglucosaminyltransferase I deficiency in Arabidopsis thaliana plants lacking complex N -glycans. Biochemical Journal 2005 387 385 391 2-s2.0-17644423487 10.1042/BJ20041686 (Pubitemid 40571224)
58. Ko K., Tekoah Y., Rudd P. M., Function and glycosylation of plant-derived antiviral monoclonal antibody. Proceedings of the National Academy of Sciences of the United States of America 2003 100 13 8013 8018 2-s2.0-0038270847 10.1073/pnas.0832472100 (Pubitemid 36760086)
59. Gomord V., Denmat L. A., Fitchette-Laine A. C., Satiat-Jeunemaitre B., Hawes C., Faye L., The C-terminal HDEL sequence is sufficient for retention of secretory proteins in the endoplasmic reticulum (ER) but promotes vacuolar targeting of proteins that escape the ER. The Plant Journal 1997 11 2 313 325 10.1046/j.1365-313X.1997.11020313.x (Pubitemid 27147977)
60. Floss D. M., Sack M., Stadlmann J., Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. Plant Biotechnology Journal 2008 6 4 379 391 2-s2.0-41749093617 10.1111/j.1467-7652.2008.00335.x (Pubitemid 351490229)
61. Petruccelli S., Otegui M. S., Lareu F., A KDEL-tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds. Plant Biotechnology Journal 2006 4 5 511 527 2-s2.0-33747599863 10.1111/j.1467-7652. 2006.00200.x (Pubitemid 44267795)
62. Gomord V., Sourrouille C., Fitchette A. C., Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge. Plant Biotechnology Journal 2004 2 2 83 100 2-s2.0-4644373747 10.1111/j.1467-7652. 2004.00062.x (Pubitemid 40199459)
63. Conrad U., Fiedler U., Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Molecular Biology 1998 38 1-2 101 109 2-s2.0-0032168897 (Pubitemid 28403768)
64. Sharp J. M., Doran P. M., Strategies for enhancing monoclonal antibody accumulation in plant cell and organ cultures. Biotechnology Progress 2001 17 6 979 992 2-s2.0-0035543343 10.1021/bp010104t (Pubitemid 34018274)
65. Lee J. H., Park D. Y., Lee K. J., Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody. PLoS ONE 2013 8 8 e68772 10.1371/journal.pone.0068772
66. Apostolopoulos V., McKenzie I. F., Role of the mannose receptor in the immune response. Current Molecular Medicine 2001 1 4 469 474 2-s2.0-0035468913 (Pubitemid 33772953)
67. Lu Z., Lee K. J., Shao Y., Expression of GA733-Fc fusion protein as a vaccine candidate for colorectal cancer in transgenic plants. Journal of Biomedicine and Biotechnology 2012 2012 11 2-s2.0-84862293788 10.1155/2012/364240 364240
68. Schahs M., Strasser R., Stadlmann J., Kunert R., Rademacher T., Steinkellner H., Production of a monoclonal antibody in plants with a humanized N -glycosylation pattern. Plant Biotechnology Journal 2007 5 5 657 663 2-s2.0-34547568959 10.1111/j.1467-7652.2007.00273.x (Pubitemid 47196370)
69. Strasser R., Altmann F., Mach L., Glossl J., Steinkellner H., Generation of Arabidopsis thaliana plants with complex N -glycans lacking β 1,2-linked xylose and core α 1,3-linked fucose. FEBS Letters 2004 561 1-3 132 136 2-s2.0-1542358140 10.1016/S0014-5793(04)00150-4 (Pubitemid 38317309)
70. Cox K. M., Sterling J. D., Regan J. T., Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nature Biotechnology 2006 24 12 1591 1597 2-s2.0-33845711353 10.1038/nbt1260 (Pubitemid 44967485)
71. Forthal D. N., Gach J. S., Landucci G., Fc-glycosylation influences Fc γ receptor binding and cell-mediated anti-hivactivity of monoclonal antibody 2G12. The Journal of Immunology 2010 185 11 6876 6882 2-s2.0-78650656127 10.4049/jimmunol.1002600
72. Cabanes-Macheteau M., Fitchette-Laine A., Loutelier-Bourhis C., N -glycosylation of a mouse IgG expressed in transgenic tobacco plants. Glycobiology 1999 9 4 365 372 2-s2.0-0032931237 (Pubitemid 29182152)
73. Apweiler R., Hermjakob H., Sharon N., On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta 1999 1473 1 4 8 2-s2.0-0032754473 10.1016/S0304-4165(99) 00165-8
74. Fukuda M. N., Sasaki H., Lopez L., Fukuda M., Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood 1989 73 1 84 89 2-s2.0-0024497455 (Pubitemid 19040958)
75. Castilho A., Strasser R., Stadlmann J., In planta protein sialylation through overexpression of the respective mammalian pathway. The Journal of Biological Chemistry 2010 285 21 15923 15930 2-s2.0-77952408200 10.1074/jbc.M109.088401
76. Egrie J. C., Browne J. K., Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrology Dialysis Transplantation 2001 16 supplement 3 3 13 2-s2.0-0034949634 (Pubitemid 32591159)
77. Ngantung F. A., Miller P. G., Brushett F. R., Tang G. L., Wang D. I., RNA interference of sialidase improves glycoprotein sialic acid content consistency. Biotechnology and Bioengineering 2006 95 1 106 119 2-s2.0-33748438957 10.1002/bit.20997 (Pubitemid 44342355)
78. Erbayraktar S., Grasso G., Sfacteria A., Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proceedings of the National Academy of Sciences of the United States of America 2003 100 11 6741 6746 2-s2.0-0037974734 10.1073/pnas.1031753100 (Pubitemid 36666650)